3,000,000 SHARES OF COMMON STOCK VOLITIONRX LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • August 2nd, 2022 • Volitionrx LTD • In vitro & in vivo diagnostic substances • New York
Contract Type FiledAugust 2nd, 2022 Company Industry JurisdictionThe undersigned, VolitionRx Limited, a company incorporated under the laws of Delaware (collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the Registration Statement as being subsidiaries or affiliates of VolitionRx Limited, the “Company”), hereby confirms its agreement (this “Agreement”) with the several underwriters (such underwriters, including the Representative (as defined below), the “Underwriters” and each an “Underwriter”) named in Schedule I hereto for which Newbridge Securities Corporation is acting as representative to the several Underwriters (the “Representative” and if there are no Underwriters other than the Representative, references to multiple Underwriters shall be disregarded and the term Representative as used herein shall have the same meaning as Underwriter) on the terms and conditions set forth herein.